Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost Academic Article uri icon

Overview

MeSH Major

  • Gynecologic Surgical Procedures
  • Medicare
  • Pelvic Organ Prolapse
  • Surgical Mesh

abstract

  • Sacral neuromodulation implantation was more expensive than onabotulinumtoxinA injection. However, patients who underwent sacral neuromodulation had a lower complication rate than patients treated with onabotulinumtoxinA. A quality improvement collective database must be created to track information on onabotulinumtoxinA and sacral neuromodulation treatment. This would help generate better performance and comparative data for patient and physician decision making.

publication date

  • January 2020

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/JU.0000000000000462

PubMed ID

  • 31347949

Additional Document Info

start page

  • 179

end page

  • 184

volume

  • 203

number

  • 1